Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-19

FDA Approved: GIMOTI — Original Application (Evoke Pharma, Inc.)

View source ↗

Summary

FDA approved GIMOTI (metoclopramide hydrochloride) from Evoke Pharma under an Original Application (NDA209388) for the treatment of gastroparesis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GIMOTI (metoclopramide hydrochloride)

Snippet

ORIG AP for GIMOTI (METOCLOPRAMIDE HYDROCHLORIDE)